Search

Search Constraints

You searched for: Author/Creator Ahmed, Rebekah M

Search Results

1. 013 Lipid metabolism and body composition in frontotemporal dementia-amyotrophic lateral sclerosis spectrum: effect on survival and disease progression. Issue 6 (24th May 2018)

2. 015 Unravelling psychosis in motor neurone disease – a study of clinical features, cognition, and survival. (29th July 2019)

3. 015 Unravelling psychosis in motor neurone disease – a study of clinical features, cognition, and survival. (29th July 2019)

4. A novel use of arterial spin labelling MRI to demonstrate focal hypoperfusion in individuals with posterior cortical atrophy: a multimodal imaging study. Issue 9 (5th January 2016)

5. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020)

6. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020)

7. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020)

8. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020)

9. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020)

10. A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia. Issue 11 (16th November 2020)